Mitral Regurgitation - Valvular Heart Disease Guidelines

Mitral Regurgitation Guidelines App

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/674356

Contents of this Issue

Navigation

Page 1 of 15

Key Points Î Patients with VHD may present with a heart murmur, symptoms, or incidental findings of valvular abnormalities on noninvasive testing. Î The initial evaluation should include a detailed history and physical exam, ECG, chest x-ray, and transthoracic echocardiogram. Î Decisions about treatment are based primarily on the presence or absence of symptoms, severity of VHD, and response of the ventricle to pressure or volume overload imposed by VHD. Î VHD requires a multidisciplinary team and approach for its diagnosis and management. Î Reasons for valve intervention are to improve symptoms, prolong survival, and reduce the risk of complications. Î An evaluation of the surgical or interventional risk for each individual patient should be performed if intervention is indicated which includes a standard surgical risk score, along with consideration of comorbidites, frailty, and procedure specfic impediments. Î Follow-up of patients with VHD is important to assess symptom status, provide patient education, and monitor disease severity, typically with periodic echocardiography.

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Mitral Regurgitation Guidelines App